[1]
“Efficacy of Deucravacitinib in Moderate to Severe Scalp Psoriasis: Analysis of Complete Clearance of Scalp Disease and Symptoms”, J of Skin, vol. 8, no. 6, p. s430, Nov. 2024, doi: 10.25251/skin.8.supp.430.